The 4th Bacteriophage Therapy Summit has chosen to be digital to provide the fastest route to in-depth, global discussions with organizations navigating regulatory approval for phage formulation and manufacturing beyond the US. This meeting provides an unmissable opportunity to network with the key stakeholders making strategic decisions on advancing bacteriophage therapies for human health, as well as considering commercial opportunities in wider applications. In choosing to be a digital conference, we are prioritizing and ensuring exposure to key global leaders from both the US and Europe seeking to expand and develop their pipelines into marketed products.
Who Will You Meet?
With advanced access to the attendee list and the ability to invite stakeholders from anywhere in the world, we will help you organize pre-scheduled 121 meetings with individuals key to your business development objectives so you can start the conference ready to maximize every minute.
What the Industry Is Looking For?
Take advantage of our carefully compiled audience of industry professionals and maximize your opportunity to form long-lasting relationships with organizations specifically seeking solutions in specialized delivery systems like inhalation, gene sequencing, and scaling up from laboratory scale, among other tools and techniques to better formulate phage cocktails.
What Can the 4th Bacteriophage Therapy Summit Do for You?
Demonstrate your technology solutions to C-level executives from leading pharma, biotech, and academia and strengthen your collaborations, necessary to deliver effective and commercially successful bacteriophage therapies.
3 Key Reasons to Partner:
Secure a virtual exhibition booth to present and position your capabilities to developers who are actively seeking new solutions to optimize drug development inefficiencies
Network 121 with stakeholders during multiple coordinated networking sessions to first-hand understand their requirements and present your solution
Deliver a presentation online and influence the thinking of the most engaged bacteriophage therapy industry experts working to identify new promising solutions